A case-control study demonstrated that serum levels of IL-6 and high-sensitivity C-reactive protein (hs-CRP) were significantly associated with the risk of mild cognitive impairment (MCI) among Chinese patients with T2D (41). This evidence concerns the gene IL6 and type 2 diabetes mellitus.